• No results found

Carbide/nitride grain refined rare earth iron boron permanent magnet and method of making

N/A
N/A
Protected

Academic year: 2020

Share "Carbide/nitride grain refined rare earth iron boron permanent magnet and method of making"

Copied!
40
0
0

Loading.... (view fulltext now)

Full text

(1)

Iowa State University Patents

Iowa State University Research Foundation, Inc.

9-8-1998

Carbide/nitride grain refined rare earth-iron-boron

permanent magnet and method of making

R. William McCallum

Iowa State University, mccallum@ameslab.gov

Daniel J. Branagan

Iowa State University

Follow this and additional works at:

http://lib.dr.iastate.edu/patents

Part of the

Materials Science and Engineering Commons

This Patent is brought to you for free and open access by the Iowa State University Research Foundation, Inc. at Iowa State University Digital Repository. It has been accepted for inclusion in Iowa State University Patents by an authorized administrator of Iowa State University Digital Repository. For more information, please contactdigirep@iastate.edu.

Recommended Citation

McCallum, R. William and Branagan, Daniel J., "Carbide/nitride grain refined rare earth-iron-boron permanent magnet and method of making" (1998).Iowa State University Patents. 273.

(2)

comprising RE, Fe and/or Co, and B (where RE is one or more rare earth elements) and 2) TR (where TR is a transition metal selected from at least one of Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, and Al) and at least one of C and N are provided in the base alloy composition melt in substantially stoichiometric amounts to form a thermodynamically stable compound (e.g. TR carbide, nitride or carbonitride). The melt is rapidly solidified in a manner to form particulates having a substantially amorphous (metallic glass) structure and a dispersion of primary TRC, TRN and/or TRC/N precipitates. The amorphous particulates are heated above the crystallization temperature of the base alloy composition to nucleate and grow a hard magnetic phase to an optimum grain size and to form secondary TRC, TRN and/or TRC/N precipitates dispersed at grain boundaries. The crystallized particulates are consolidated at an elevated temperature to form a shape. During elevated temperature consolidation, the primary and secondary precipitates act to pin the grain boundaries and minimize deleterious grain growth that is harmful to magnetic properties.

Keywords

Ames Laboratory, Materials Science and Engineering

Disciplines

Materials Science and Engineering

(3)

United States Patent [19]

McCallum et al.

US005803992A

[11] Patent Number:

[45]

Date of Patent:

5,803,992

Sep. s, 1998

[54]

[75]

[73]

CARBIDE/NITRIDE GRAIN REFINED RARE FOREIGN PATENT DOCUMENTS EARTH-IRON-BORON PERMANENT

0443647 8/1991 European Pat. Off. ... .. 148/302

MAGNET AND METHOD OF MAKING 5-105902 4/1993 Japan ... .. 148/302

Inventors: R. William McCallum; Daniel J.

Branagan, both of Ames, Iowa Primary Examiner—John Sheehan

Attorney, Agent, or Firm—EdWard J. Timmer Assignee: Iowa State University Research

Foundation, Inc., Ames, Iowa [57] ABSTRACT

A method of making a permanent magnet Wherein 1) a melt

Appl. No.: 564,425 is formed having a base alloy composition comprising RE,

. _ Fe and/or Co, and B (Where RE is one or more rare earth

Flled' NOV‘ 29’ 1995 elements) and 2) TR (Where TR is a transition metal selected

. . from at least one of Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, and Al) Related U'S' Apphcatlon Data and at least one of C and N are provided in the base alloy Division of Ser_ No 2327837’ Apr‘ 25’ 1994’ Pat‘ NO‘ composition melt in substantially stoichiometric amounts to

5,486,240' form a thermodynamically stable compound (eg TR

6 carbide, nitride or carbonitride). The melt is rapidly solidi

IIlt- Cl- ... .. ?ed in a manner to form particulates having a Substantially

U.S. Cl. ... .. 148/302; 420/83; 420/121; amorphous (metallic glass) Structure and a dispersion of

148/121 primary TRC, TRN and/or TRC/N precipitates. The amor

Fleld of Search ... .. phous particulates are heated above the Crystallization tern

420/83, 121 perature of the base alloy composition to nucleate and groW

_ a hard magnetic phase to an optimum grain siZe and to form

References Clted secondary TRC, TRN and/or TRC/N precipitates dispersed

Us PATENT DOCUMENTS at grain boundaries. The crystallized particulates are con

sohdated at an elevated temperature to form a shape. During

4,597,938 7/1986 Matsuura et al. ... .. 419/23 elevated temperature Consolidation, the primary and Second

476017875 7/1986 Yamamoto et a1- - ~~ 419/23 ary precipitates act to pin the grain boundaries and minimize

478017340 1/1989 Inoue et a1‘ """" " 148/103 deleterious grain groWth that is harmful to magnetic prop

4,919,732 4/1990 Yang et al. 148/103 er?es

5,162,064 11/1992 Kim et al. . 148/302 ' 5,172,751 12/1992 Croat ... .. 148/101

5,240,513 8/1993 McCallum et al. ... .. 148/104 5 Claims, 32 Drawing Sheets

1 a

0.8 - 4,

z. ..

m .

a.

E 0

(D

2

1

*5 0.4 — a

E

Q

l

A

0:

° |

0.2 —

9

‘141.1

t

1::

4 l 1 1 1 I I l ‘ ~

0 ii I l " . | ,

2O 3O 4O 6O 7O 8O 90

TWO ‘TH ETA

(4)
(5)

U.S. Patent

Sep. 8,1998

Sheet 2 0f 32

5,803,992

m

.QE

0:.

4

(PM IP-OZC:

Om

ON

00

Om

0V

ON

ON

(6)

5F

1“

(7)

U.S. Patent

Sep. 8,1998

Sheet 4 0f 32

5,803,992

(8)

A.

A l

60

TWO-TH ETA

‘NC

50

9

Nd2Fe14B A

FIG.

6

(9)
(10)

mw

.QE

E3

on

(11)

5,803,992

on

.0

E

.

qua

cm.“

32

cm

52

cm

52

2

008m uooow 008w 058

Sep. 8, 1998

Sheet 8 0f 32

BHmax (MGOe)

U.S. Patent

0

D)! 1° 80)!

semadoxd onau?nw

mp

(12)

BHmax (MGOe)

E2

on

Uooow

on

.61

53

cm

0°08

Ow...

NF

S2

{D1 1° aOX

samadaxd ogau?ew

mP

(13)

U.S. Patent

Sep.8,1998

Sheet 10 0f 32

5,803,992

12

10 - B 6 4 2 0

800°C

20

Min

a

LIJ

2),

2% '\_

38 (9

LL.

5

| l ‘ l 2

{D1 1° 903

(14)

1 2

-

10

a s 4

800°C

120

Min

800°C 300°C

30

Min

60

Min

FIG.

7

F

Msat

560°C

20

Min

As-Sp1m

l l

0 10 O

0}! 1° 90}!

sagladard opeu?nw

(15)

U.S. Patent

Sep.8,1998

Sheet 12 0f 32

5,803,992

BHmax (MGOe)

0N

.QE

52

om?

B2

ow

52

cm

52

mH

Oooom Uooow 000cm Uooow

O _ _ A A

N l.

BB2 4 ibj

1 [ml

aw

w

|

Hamm J

or

NF

~32

O

OH

1° 90H

samadmd opau?eyq

m2.

(16)

BHmax (MGOe)

83cm

In

mg

on

E2

ma

U008 .

O

_ 0&8

0008

0&8

N I

W

m

E

w/ |

.V

l l .522

H

11G

a‘ 35mm . j

m I

m |

w,»

Owl

NF

9.

ON

0}! 1° 90X

(17)

U.S. Patent

Sep.8,1998

Sheet 14 0f 32

5,803,992

BHmax (MGOe)

12

10

a - s — 4 — 2 — 0

800°C

120Min

800°C

60

Min

FIG.

71

Msat

Hc

800°C

30

Min

c;

800°C

13

Min

20

DH

1° 90X

(18)

BHmnx (MGOe)

12

—- 10

a s 4 2 0

Q

_

*6

800°C

120

Min

800°C

60

Min

FIG.

7J

M

800°C

30

Min

5x

800°C

13

Min

I l l

O 10 O

(19)
(20)

BHmax (MGOe)

2

(21)

U.S. Patent

Sep.8,1998

Sheet 18 0f 32

5,803,992

(22)

Or

NF

(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(40)

References

Related documents

The diagnosis can be suspected on newborn screening, but is established by demonstration of low plasma free carnitine concentration (<5 μ M, normal 25-50 μ M), reduced

Flash – Press to perform the following functions: Disconnect and recall dial tone on a outside line; access Centrex or PBX features; enter a pause or flash signal when

This drug work hs an incretin effect and reduces blood glucose by stimulating insulin release and preventing glucagon secretion.. The levels of GLP-1 seem to

H-atoms were placed in calculated positions (C—H 0.95 or 0.98 Å) and were included in the refinement in the riding model approximation, with U (H) set to 1.2 U eq (C) or 1.5 U eq

damage of some branches (ie, spinal accessory nerve) is associated with intractable pain in the shoulder and

The protocol offers the same type of service to applications as TCP (i.e., reliable byte stream), and it provides the components to establish and use multiple TCP flows across

The complex of the three pathogens, the bacteria Anaplasma marginale and the protozoan parasites Babesia bovis and Babesia bigemina, is a tick-borne disease

The objective of this study was to estimate the cost- effectiveness of FSC compared to salmeterol for maintenance therapy in patients with severe COPD using data pooled from